Clinical Trials Directory

Trials / Completed

CompletedNCT02677779

CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers

A Randomised, Open Label, Controlled Clinical Study to Evaluate the Efficacy and Safety of CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Azienda Ospedaliero-Universitaria Careggi · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is aimed at comparing debridement either with CO2 laser or traditional surgery in patients with infected diabetic foot ulcers. The principal endpoint is bacterial load immediately after treatment.

Detailed description

The present study is designed to assess the antimicrobial effect of a single CO2 laser beam (DEKA SmartXide2 c80-El.En, Florence Italy) in the treatment of diabetic infected foot ulcers. CO2 laser debridement will be compared with standard surgical care. The primary efficacy endpoint will be the reduction of bacterial load between pre- and immediately after debridement. Secondary endpoints will be adverse events and pain during treatment. Two bacterial sample with a flocked nylon swab will be collected before and after debridement.

Conditions

Interventions

TypeNameDescription
PROCEDURECO2 laserSingle session of CO2 laser debridement
PROCEDUREtraditional surgerySingle session of traditional debridement

Timeline

Start date
2016-01-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2016-02-09
Last updated
2016-12-06
Results posted
2016-12-06

Source: ClinicalTrials.gov record NCT02677779. Inclusion in this directory is not an endorsement.